Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Storer

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Cancer|January 15, 1992
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factorJ H Schiller, P L Witt, B Storer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB studyJ H Schiller, J A Hank, M Khorsand, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1996
Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanomaM R Albertini, J Gan, P Jaeger, et al.
Bone Marrow Transplantation|September 12, 2000
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experienceJ Sierra, B Storer, J A Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2001
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationM Boeckh, R A Bowden, B Storer, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1993
A pilot phase II trial of continuous-infusion interleukin-2 followed by lymphokine-activated killer cell therapy and bolus-infusion interleukin-2 in renal cancerC Gambacorti-Passerini, J A Hank, M R Albertini, et al.
Applied Clinical Informatics|March 25, 2026
Qualitative User-Centered Design: Programming Changes in a Self-Management Blood Pressure ApplicationShannon M Canfield, Abigail J Rolbiecki, Parijat Ghosh, et al.
The New England Journal of Medicine|February 15, 2001
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancersW I Bensinger, P J Martin, B Storer, et al.
Journal of Molecular and Cellular Cardiology|May 9, 1998
Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3T L Yue, C Wang, A M Romanic, et al.
Circulation|November 18, 2000
Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injuryT L Yue, L Vickery-Clark, C S Louden, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Cancer|January 15, 1992
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factorJ H Schiller, P L Witt, B Storer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB studyJ H Schiller, J A Hank, M Khorsand, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1996
Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanomaM R Albertini, J Gan, P Jaeger, et al.
Bone Marrow Transplantation|September 12, 2000
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experienceJ Sierra, B Storer, J A Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2001
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationM Boeckh, R A Bowden, B Storer, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1993
A pilot phase II trial of continuous-infusion interleukin-2 followed by lymphokine-activated killer cell therapy and bolus-infusion interleukin-2 in renal cancerC Gambacorti-Passerini, J A Hank, M R Albertini, et al.
Applied Clinical Informatics|March 25, 2026
Qualitative User-Centered Design: Programming Changes in a Self-Management Blood Pressure ApplicationShannon M Canfield, Abigail J Rolbiecki, Parijat Ghosh, et al.
The New England Journal of Medicine|February 15, 2001
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancersW I Bensinger, P J Martin, B Storer, et al.
Journal of Molecular and Cellular Cardiology|May 9, 1998
Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3T L Yue, C Wang, A M Romanic, et al.
Circulation|November 18, 2000
Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injuryT L Yue, L Vickery-Clark, C S Louden, et al.
Pageof 13